COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic. J Am Acad Dermatol. 2020 09; 83(3):e251-e252.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Betacoronavirus
Clinical Decision-Making
Coronavirus Infections
Dermatitis, Atopic
Dermatology
Humans
Interleukin-4 Receptor alpha Subunit
Pandemics
Pneumonia, Viral
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Risk Assessment
Treatment Outcome
authors with profiles
Jashin J Wu
Donovan G Kearns
Vipawee S Chat
Shelley Uppal